Ahmad Shannar
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research 1
-
- Genomics, phytochemicals, and oxidative stress 6
- Glutathione Transferases and Polymorphisms 4
- Histone Deacetylase Inhibitors Research 4
- Epigenetics and DNA Methylation 4
-
- Nutrition, Genetics, and Disease 1
- Genetic Syndromes and Imprinting 1
-
- Autophagy in Disease and Therapy 1
Ahmad Shannar
12 papers receiving 544 citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Infectious Diseases 287
- Neurology 84
- Pharmacology 41
- Biological Psychiatry 11
- Computational Theory and Mathematics 59
Countries citing papers authored by Ahmad Shannar
This map shows the geographic impact of Ahmad Shannar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ahmad Shannar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ahmad Shannar more than expected).
Fields of papers citing papers by Ahmad Shannar
This network shows the impact of papers produced by Ahmad Shannar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ahmad Shannar. The network helps show where Ahmad Shannar may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ahmad Shannar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 4 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 6 | |
| 6 | 2023 | 6 | |
| 7 | 2023 | 7 | |
| 8 | 2023 | 2 | |
| 9 | 2022 | 8 | |
| 10 | 2022 | 41 | |
| 11 | An Update on Current Therapeutic Drugs Treating COVID-19breakdown → | 2020 | 418 |
| 12 | 2020 | 35 | |
| 13 | 2020 | 26 |
About Ahmad Shannar
Ahmad Shannar is a scholar working on Geriatrics and Gerontology, Biochemistry and Pharmaceutical Science, having authored 13 papers that have together received 561 indexed citations. Recurring topics across this work include Genomics, phytochemicals, and oxidative stress (6 papers), Glutathione Transferases and Polymorphisms (4 papers), Histone Deacetylase Inhibitors Research (4 papers), Epigenetics and DNA Methylation (4 papers), Nutrition, Genetics, and Disease (1 paper), Autophagy in Disease and Therapy (1 paper), Genetic Syndromes and Imprinting (1 paper) and SARS-CoV-2 and COVID-19 Research (1 paper). The work is most often cited by research in Infectious Diseases (287 citations), Neurology (84 citations) and Pharmacology (41 citations). Ahmad Shannar has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Ah‐Ng Tony Kong, Pochung Jordan Chou, Rebecca Mary Peter, Renyi Wu, Hsiao‐Chen Dina Kuo, Lujing Wang, Shanyi Li, Rasika R. Hudlikar, Zhigang Liu and Louis F. Amorosa. Their work appears in journals such as Carcinogenesis, Pharmaceutical Research, Molecular Nutrition & Food Research, European Journal of Pharmacology and Free Radical Biology and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.